Rare cancer drug added to PBS

25 March 2017 - A drug used to treat a rare form of cancer now widely available through the national ...

Read more →

Public summary document for Keytruda (pembrolizumab)

22 March 2017 - The public summary document for pembrolizumab for the treatment of patients with non-small-cell lung cancer from the ...

Read more →

Chemotherapy compounding payment scheme - extension to the non-mandatory claiming period

17 March 2017 - The proposed date for mandatory inclusion of the Compounder ID with eligible EFC claims is being ...

Read more →

The refusal of Medicare to fund a $60 blood test means cancer patients miss out on treatment

19 February 2017 - Mother of two Lisa Briggs and thousands of other lung cancer patients battling the nation’s deadliest ...

Read more →

Updated PBAC outcomes for November 2016

7 February 2017 - Subsequent to the deferral at the November 2016 PBAC meeting, the PBAC recommended the PBS listing of ...

Read more →

Funding cuts threat for radiation patients

6 February 2017 - Radiologists have warned that a $23.7 million cut to federal support for cancer-fighting equipment will undermine ...

Read more →

Advanced ovarian cancer treatment placed on the PBS, a move praised by doctors and patients

1 January 2017 - Women with advanced ovarian cancer can now pay significantly less for a groundbreaking drug, in a ...

Read more →

Patients battling deadly ovarian, lung cancer to have affordable access to new drugs

31 January 2017 - Sick patients battling deadly cancers will have affordable access to new drugs which usually cost more ...

Read more →

‘Precision medicine’ promises new hope for cancer sufferers

17 January 2017 - A shift from mass to personalised medicine promises new hope for cancer sufferers and health authorities, ...

Read more →

Company brings unapproved life saving drugs to Australia. But is it medicine for the rich?

5 December 2016 - When the cancer in Karen Cowley's breast spread to her spine and brain, and her current ...

Read more →

Rare cancer patients push for better medication access, say current PBS framework is unfair

18 October 2016 - Patients with rare cancers have ramped up calls on the Federal Government to change regulations around ...

Read more →

Rare cancer sufferers face long waits, high costs for treatment

16 October 2016 - Lillian Leigh was taking in the view from the train on her way home from work ...

Read more →

Costs and concerns in cancer care

5 October 2016 - Some recently developed anticancer drugs appear to be a major advance. ...

Read more →

Schedule of Pharmaceutical Benefits - 1 October 2016 update

1 October 2016 - The 1 October 2016 issue of the Schedule of Pharmaceutical Benefits sees a number of new ...

Read more →

Breast cancer drug tamoxifen listed on Pharmaceutical Benefits Scheme

1 October 2016 - More Australian women will have access to a preventative breast cancer medicine that has been listed on ...

Read more →